Multivessel vs. culprit-lesion only percutaneous coronary intervention in ST-elevation myocardial infarction.
Multivessel vs. culprit-lesion only percutaneous coronary intervention in ST-elevation myocardial infarction.
Herz. 2020 May 19;:
Authors: Feistritzer HJ, Jobs A, Desch S, Thiele H
Abstract
The optimal treatment of non-infarct-related coronary arteries in patients presenting with ST-elevation myocardial infarction (STEMI) has been a subject of debate for many years. Earlier medium-sized randomized controlled trials reported a benefit of multivessel percutaneous coronary intervention (PCI) primarily due to a reduction of subsequent revascularizations. Recently, the well-powered COMPLETE trial showed a reduction in the composite endpoint of cardiovascular mortality and myocardial reinfarction through complete revascularization. The present review summarizes the current evidence regarding revascularization strategies in STEMI patients.
PMID: 32430519 [PubMed - as supplied by publisher]
Source: Herz - Category: Cardiology Tags: Herz Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Coronary Angioplasty | Heart | Heart Attack | Jobs | Percutaneous Coronary Intervention